Adelaide Research & Scholarship: Search

Search

Results 61-70 of 136 (Search time: 0.004 seconds).

previous
1
...
4
5
6
7
8
9
10
...
14
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2015	Expression of androgen receptor splice variants in clinical breast cancers	Hickey, T.; Irvine, C.; Dvinge, H.; Tarulli, G.; Hanson, A.; Ryan, N.; Pickering, M.; Birrell, S.; Hu, D.; Mackenzie, P.; Russell, R.; Caldas, C.; Raj, G.; Dehm, S.; Plymate, S.; Bradley, R.; Tilley, W.; Selth, L.
	2015	Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation	Tarulli, G.; Laven-Law, G.; Shakya, R.; Tilley, W.; Hickey, T.
	2013	Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation	Trotta, A.; Need, E.; Selth, L.; Chopra, S.; Pinnock, C.; Leach, D.; Coetzee, G.; Butler, L.; Tilley, W.; Buchanan, G.
	2013	SGTA: A new player in the molecular co-chaperone game	Philp, L.; Butler, M.; Hickey, T.; Butler, L.; Tilley, W.; Day, T.
	2014	Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype	Robinson, J.; Hickey, T.; Warren, A.; Vowler, S.; Carroll, T.; Lamb, D.; Papoutsoglu, N.; Neal, D.; Tilley, W.; Carroll, J.
	2013	False-positive TUNEL staining observed in SV40 based transgenic murine prostate cancer models	Lawrence, M.; Blyth, B.; Ormsby, R.; Tilley, W.; Sykes, P.
	2013	Lack of high-dose radiation mediated prostate cancer promotion and low-dose radiation adaptive response in the TRAMP mouse model	Lawrence, M.; Ormsby, R.; Blyth, B.; Bezak, E.; England, G.; Newman, M.; Tilley, W.; Sykes, P.
	2015	Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms	Centenera, M.; Carter, S.; Gillis, J.; Marrocco-Tallarigo, D.; Grose, R.; Tilley, W.; Butler, L.
	2005	Androgen metabolic genes in prostate cancer predisposition and progression	Makridakis, N.; Buchanan, G.; Tilley, W.; Reichardt, J.
	2015	Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies	Chan, S.; Selth, L.; Li, Y.; Nyquist, M.; Miao, L.; Bradner, J.; Raj, G.; Tilley, W.; Dehm, S.